C81.13
Nodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Nodular sclerosis Hodgkin lymphoma is a specific subtype of Hodgkin lymphoma, a type of cancer that originates in the lymphatic system. When it affects intra-abdominal lymph nodes, it refers to cancer found in lymph nodes located within the abdominal cavity, such as those near the stomach, intestines, and other abdominal organs. This form primarily affects young adults and is characterized by distinctive tissue features seen under a microscope. Understanding this disease involves exploring its causes, symptoms, how it is diagnosed, and available treatment options.
Causes & Symptoms
Clinical Causes: The exact cause of Hodgkin lymphoma, including the nodular sclerosis subtype, remains unclear. Exposure to certain viruses, particularly the Epstein-Barr virus (EBV), has been associated with increased risk. Family history of lymphoma or other lymphatic cancers might increase susceptibility. Environmental factors, including exposure to certain chemicals or radiation, could play a role. Immune system suppression, whether due to medications or inherited conditions, may contribute to development.
Key Symptoms: Swelling or lumps in the abdomen due to enlarged intra-abdominal lymph nodes. Persistent abdominal pain or discomfort. Unexplained weight loss and loss of appetite. Fever without an obvious infection, often recurring. Night sweats and fatigue. Feeling of fullness or pressure in the abdominal area. Sometimes, symptoms related to compression of nearby organs or structures.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and specialized testing. Initially, physical examinations may reveal enlarged abdominal lymph nodes. Confirmatory tests include: - Imaging studies such as CT scans or PET scans to visualize the lymph nodes and affected areas. - Biopsy of the enlarged lymph node or affected tissue to examine under a microscope, which helps identify characteristic features of nodular sclerosis. - Blood tests to assess overall health and detect abnormal levels of certain markers. - Additional procedures, like bone marrow biopsies, may be performed to determine the extent of disease spread.
Treatment Protocols: Treatment strategies for nodular sclerosis Hodgkin lymphoma typically include chemotherapy, radiation therapy, or a combination of both. The choice of therapy depends on factors such as the disease stage and patient's overall health. Common approaches involve: - Chemotherapy regimens designed to target and destroy cancer cells. - Radiation therapy targeted at affected lymph nodes to minimize exposure to surrounding tissue. - In some cases, targeted therapy or immunotherapy may be considered. - Follow-up care is essential to monitor for remission and manage potential side effects. - Supportive care, including nutritional support and psychosocial services, can help improve quality of life during treatment.
Clinical Advice & FAQs
Billing Guidance
Is C81.13 a billable ICD-10 code?
Yes, C81.13 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.13?
Clinical documentation must specify the nature of Nodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
